Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers. 1987

D A Goldstein, and Y K Tan, and S J Soldin
Department of Clinical Pharmacology, University of Toronto, Ontario, Canada.

Salbutamol was administered to sixteen healthy male volunteers intravenously and by mouth in liquid, tablet, and capsule form using a Latin-Squares design. Pharmacokinetic parameters from intravenous data were similar to previously reported values obtained with oral administration, with a mean terminal half-life of 3.8 h and a mean clearance of 439 ml X min-1 X 1.73 m-2. Peak plasma concentrations of 10-20 ng X ml-1 were obtained 1-3 h following oral administration. The absolute bioavailability of each of the oral preparations was 44%. While statistically significant differences in lag time and time to peak concentration were noted among the various oral preparations, the drug is rapidly absorbed in all three dosage forms and the observed differences are unlikely to be of clinical significance.

UI MeSH Term Description Entries
D008297 Male Males
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000420 Albuterol A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. Salbutamol,2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol,Albuterol Sulfate,Proventil,Sultanol,Ventolin
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

D A Goldstein, and Y K Tan, and S J Soldin
July 2002, Acta pharmacologica Sinica,
D A Goldstein, and Y K Tan, and S J Soldin
June 2009, International journal of clinical pharmacology and therapeutics,
D A Goldstein, and Y K Tan, and S J Soldin
August 2001, Yao xue xue bao = Acta pharmaceutica Sinica,
D A Goldstein, and Y K Tan, and S J Soldin
August 2017, Clinical pharmacology and therapeutics,
D A Goldstein, and Y K Tan, and S J Soldin
October 2003, Clinical therapeutics,
D A Goldstein, and Y K Tan, and S J Soldin
January 1999, Biopharmaceutics & drug disposition,
D A Goldstein, and Y K Tan, and S J Soldin
November 1998, British journal of clinical pharmacology,
D A Goldstein, and Y K Tan, and S J Soldin
October 1999, Antimicrobial agents and chemotherapy,
D A Goldstein, and Y K Tan, and S J Soldin
November 1992, International journal of clinical pharmacology, therapy, and toxicology,
D A Goldstein, and Y K Tan, and S J Soldin
February 1991, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!